South Korea Pharmaceutical Contract Manufacturing Market Size & Outlook
The pharmaceutical contract manufacturing market in South Korea is expected to reach a projected revenue of US$ 5,724.5 million by 2033. A compound annual growth rate of 11.5% is expected of South Korea pharmaceutical contract manufacturing market from 2026 to 2033.
Revenue, 2025 (US$M)
$2,424.1
Estimate, 2026 (US$M)
$2,677.8
Forecast, 2033 (US$M)
$5,724.5
CAGR, 2026 - 2033
11.5%
Global Market
Related Markets
South Korea pharmaceutical contract manufacturing market highlights
- The South Korea pharmaceutical contract manufacturing market generated a revenue of USD 2,424.1 million in 2025 and is expected to reach USD 5,724.5 million by 2033.
- The South Korea market is expected to grow at a CAGR of 11.5% from 2026 to 2033.
- In terms of segment, api manufacturing was the largest revenue generating service in 2025.
- Packaging Services is the most lucrative service segment registering the fastest growth during the forecast period.
Pharmaceutical contract manufacturing market data book summary
| Market revenue in 2025 | USD 2,424.1 million |
| Market revenue in 2033 | USD 5,724.5 million |
| Growth rate | 11.5% (CAGR from 2026 to 2033) |
| Largest segment | Api manufacturing |
| Fastest growing segment | Packaging Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | API Manufacturing, Packaging Services, Finished Drug Product Manufacturing |
| Key market players worldwide | Abbvie Contract Manufacturing, Almac Group, Boehringer Ingelheim, Catalent Inc, Dr. Reddy's Laboratories Ltd., Fareva, FUJIFILM Diosynth Biotechnologies, Jubilant HollisterStier, Lonza Group Ltd ADR, Thermo Fisher Scientific, Inc. (Patheon), Pfizer CentreOne, Recipharm, Samsung BioLogics, Siegfried Holding AG, Vetter Pharma, Wuxi AppTec Co Ltd |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.7% of the global pharmaceutical contract manufacturing market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China pharmaceutical contract manufacturing market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 33,050.3 million by 2033.
No credit card required*
Publish Date: Mar 26, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Pharmaceutical Contract Manufacturing Market Scope
Pharmaceutical Contract Manufacturing Market segmentation & scope
Others
Pharmaceutical Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | www.boehringer-ingelheim.com/ |
| Wuxi AppTec Co Ltd | View profile | 41,116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | www.wuxiapptec.com |
| Catalent Inc | View profile | 17,219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | www.catalent.com |
| Siegfried Holding AG | View profile | 4,180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | www.siegfried.ch |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | www.recipharm.com |
| Samsung BioLogics | View profile | 1001-5000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | www.samsungbiologics.com/ |
| Almac Group | View profile | 1001-5000 | Craigavon, Craigavon, United Kingdom, Europe | www.almacgroup.com |
| Lonza Group Ltd ADR | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Jubilant HollisterStier | View profile | 1001-5000 | Spokane, Washington, United States, North America | www.jublhs.com |
| Pfizer CentreOne | View profile | - | New York, New York, United States, North America | www.pfizercentreone.com |
South Korea Pharmaceutical Contract Manufacturing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Pharmaceutical Contract Manufacturing Market Outlook will help companies and investors design strategic landscapes.
Api Manufacturing was the largest segment with a revenue share of 78.03% in 2025.
Horizon Databook has segmented the South Korea pharmaceutical contract manufacturing market based on api manufacturing, packaging services, finished drug product manufacturing covering the revenue growth of each sub-segment from 2021 to 2033.
- South Korea Pharmaceutical Contract Manufacturing Market Service Outlook (Revenue, USD Million , 2021-2033)
- API Manufacturing
- Packaging Services
- Finished Drug Product Manufacturing
- South Korea Pharmaceutical Contract Manufacturing Market Product Outlook (Revenue, USD Million , 2021-2033)
- Small Molecule
- Biologics
- South Korea Pharmaceutical Contract Manufacturing Market Drug Type Outlook (Revenue, USD Million , 2021-2033)
- Generics
- Branded
- South Korea Pharmaceutical Contract Manufacturing Market Scale of Operation Outlook (Revenue, USD Million , 2021-2033)
- Batch
- Continuous
- South Korea Pharmaceutical Contract Manufacturing Market Workflow Outlook (Revenue, USD Million , 2021-2033)
- Clinical
- Commerical
- South Korea Pharmaceutical Contract Manufacturing Market Application Outlook (Revenue, USD Million , 2021-2033)
- Oncology
- Infectious Diseases
- Neurological Disorders
- Cardiovascular Disease
- Metabolic Disorders
- Autoimmune Diseases
- Respiratory Diseases
- Ophthalmology
- Gastrointestinal Disorders
- Hormonal Disorders
- Hematological Disorders
- Others
- South Korea Pharmaceutical Contract Manufacturing Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical Companies
- Biotechnology companies
- South Korea Pharmaceutical Contract Manufacturing Market Company Size Outlook (Revenue, USD Million , 2021-2033)
- Small
- Medium
- Large
Reasons to subscribe to Pharmaceutical Contract Manufacturing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Pharmaceutical Contract Manufacturing Market Outlook databook
- Our clientele includes a mix of Pharmaceutical Contract Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea Pharmaceutical Contract Manufacturing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Korea Pharmaceutical Contract Manufacturing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Korea Pharmaceutical Contract Manufacturing Market, 2021-2033 (US$M)
South Korea pharmaceutical contract manufacturing market statistics, by service, 2021-2033 (US$M)
